U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H38N4O6.2ClH
Molecular Weight 599.546
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IGANIDIPINE DIHYDROCHLORIDE

SMILES

Cl.Cl.COC(=O)C1=C(C)NC(C)=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OCC(C)(C)CN3CCN(CC=C)CC3

InChI

InChIKey=PJGTYHKZUAHNHC-UHFFFAOYSA-N
InChI=1S/C28H38N4O6.2ClH/c1-7-11-30-12-14-31(15-13-30)17-28(4,5)18-38-27(34)24-20(3)29-19(2)23(26(33)37-6)25(24)21-9-8-10-22(16-21)32(35)36;;/h7-10,16,25,29H,1,11-15,17-18H2,2-6H3;2*1H

HIDE SMILES / InChI

Molecular Formula C28H38N4O6
Molecular Weight 526.6245
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iganidipin is a new dihydropiridynic derivative of calcium antagonist. It is the only currently available calcium antagonist in the form of ophthalmic solution. Its topical administration increases ipsilateral optic nerve head blood flow in rabbits and monkeys and inhibits the contraction of blood vessels induced by endothelin -1. Iganidipin is also used for treat Angina pectoris and Hypertension.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia.
2006 Feb 3
Patents

Patents

Sample Use Guides

for rabbit: (14)C-iganidipine solution (0.03%, 30 microL) was instilled into one eye
Route of Administration: Topical
In Vitro Use Guide
Iganidipine (0.01-1 microM) increased the retinal ganglion cells (RGC) viability
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:12:36 GMT 2023
Edited
by admin
on Sat Dec 16 05:12:36 GMT 2023
Record UNII
VEE2U6QF71
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IGANIDIPINE DIHYDROCHLORIDE
Common Name English
3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 3-(2,2-DIMETHYL-3-(4-(2-PROPEN-1-YL)-1-PIPERAZINYL)PROPYL) 5-METHYL ESTER, HYDROCHLORIDE (1:2)
Common Name English
NKY-722
Code English
KIRENIDIPINE HYDROCHLORIDE
JAN  
Common Name English
KIRENIDIPINE DIHYDROCHLORIDE
Common Name English
3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 2,2-DIMETHYL-3-(4-(2-PROPENYL)-1-PIPERAZINYL)PROPYL METHYL ESTER, DIHYDROCHLORIDE
Common Name English
KIRENIDIPINE HYDROCHLORIDE [JAN]
Common Name English
Code System Code Type Description
PUBCHEM
164031
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
CAS
117241-46-0
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID40922373
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
FDA UNII
VEE2U6QF71
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY